Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: FDA shares a warning | Cardiologist arrested | New TAVR valve impresses | What happened to private practices?

News You Need to Know Today
Week in Review: FDA shares a warning | Cardiologist arrested | New TAVR valve impresses | What happened to private practices?
Saturday, May 11, 2024
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible. 

READ MORE >
FDA warning alert exclamation computer
Share on Twitter Share on Facebook Share on Linkedin

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

Share on Twitter Share on Facebook Share on Linkedin
FDA warning alert exclamation computer
The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible. 
READ MORE >

North Carolina cardiologist arrested for sex crimes

The 61-year-old physician is currently in jail. He was previously in the news for allegedly implanting stents that were not medically necessary, agreeing to pay a hefty sum to settle.

READ MORE >
offender-trouble-handcuffs-police-arrest-2102488.jpg
Share on Twitter Share on Facebook Share on Linkedin

North Carolina cardiologist arrested for sex crimes

Share on Twitter Share on Facebook Share on Linkedin
offender-trouble-handcuffs-police-arrest-2102488.jpg
The 61-year-old physician is currently in jail. He was previously in the news for allegedly implanting stents that were not medically necessary, agreeing to pay a hefty sum to settle.
READ MORE >

New-look TAVR valve shows early promise in patients with severe AS

One-year data presented at SCAI's annual meeting suggest interventional cardiologists could soon have a new way to treat severe aortic stenosis.

READ MORE >
The DurAVR TAVR system from Anteris Technologies. A new biomimetic transcatheter aortic valve replacement (TAVR) system from Anteris Technologies could provide cardiologists with a new way to treat severe aortic stenosis (AS), according to new one-year data presented at SCAI 2024 Scientific Sessions, the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI). The DurAVR TAVR system, made from a single piece of anti-calcification ADAPT tissue patented by Anteris.
Share on Twitter Share on Facebook Share on Linkedin

New-look TAVR valve shows early promise in patients with severe AS

Share on Twitter Share on Facebook Share on Linkedin
The DurAVR TAVR system from Anteris Technologies. A new biomimetic transcatheter aortic valve replacement (TAVR) system from Anteris Technologies could provide cardiologists with a new way to treat severe aortic stenosis (AS), according to new one-year data presented at SCAI 2024 Scientific Sessions, the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI). The DurAVR TAVR system, made from a single piece of anti-calcification ADAPT tissue patented by Anteris.
One-year data presented at SCAI's annual meeting suggest interventional cardiologists could soon have a new way to treat severe aortic stenosis.
READ MORE >

What happened to cardiology's private practices?

Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.

READ MORE >
ACC President Cathie Biga explains how cardiologist employment models undergoing a profound transformation during an interview with Cardiovascular Digital Editor Dave Fornell at ACC 2024.
Share on Twitter Share on Facebook Share on Linkedin

What happened to cardiology's private practices?

Share on Twitter Share on Facebook Share on Linkedin
ACC President Cathie Biga explains how cardiologist employment models undergoing a profound transformation during an interview with Cardiovascular Digital Editor Dave Fornell at ACC 2024.
Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.
READ MORE >

FDA announces Class I recall after insulin pump software causes 224 injuries

The new recall impacts more than 85,000 devices. If users update their iPhone app as recommended, however, they can continue using the insulin pump as directed. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces Class I recall after insulin pump software causes 224 injuries

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
The new recall impacts more than 85,000 devices. If users update their iPhone app as recommended, however, they can continue using the insulin pump as directed. 
READ MORE >

Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE

The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.

READ MORE >
Hēlo PE Thrombectomy System developed by U.S. medical device company Endovascular Engineering.
Share on Twitter Share on Facebook Share on Linkedin

Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE

Share on Twitter Share on Facebook Share on Linkedin
Hēlo PE Thrombectomy System developed by U.S. medical device company Endovascular Engineering.
The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.
READ MORE >

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?

Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.

READ MORE >
doctor examines patient data on their tablet
Share on Twitter Share on Facebook Share on Linkedin

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?

Share on Twitter Share on Facebook Share on Linkedin
doctor examines patient data on their tablet
Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.
READ MORE >

ChatGPT passes interventional cardiology certification exam

The popular AI chatbot's performance highlighted both its strengths and its weaknesses. It can answer multiple-choice questions, for example, but it struggles with consistency. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

ChatGPT passes interventional cardiology certification exam

Share on Twitter Share on Facebook Share on Linkedin
The popular AI chatbot's performance highlighted both its strengths and its weaknesses. It can answer multiple-choice questions, for example, but it struggles with consistency. 
READ MORE >

AI helps cardiologists track new drug's effect on inflammation

The combination of AI and CT helped Nehal Mehta, MD, and colleagues track the performance of a new drug designed to target coronary inflammation. 

READ MORE >
Interview with Nehal Mehta, MD, University of Pennsylvania, who explains how coronary inflammation can be seen using AI on cardiac CT scans to better risk stratify patients and begin preventive drug therapy.
Share on Twitter Share on Facebook Share on Linkedin

AI helps cardiologists track new drug's effect on inflammation

Share on Twitter Share on Facebook Share on Linkedin
Interview with Nehal Mehta, MD, University of Pennsylvania, who explains how coronary inflammation can be seen using AI on cardiac CT scans to better risk stratify patients and begin preventive drug therapy.
The combination of AI and CT helped Nehal Mehta, MD, and colleagues track the performance of a new drug designed to target coronary inflammation. 
READ MORE >

The push for an independent cardiology board continues

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

READ MORE >
Jeff Kuvin, MD, explains the effort to create an new independent cardiology board. He is the ACC point person for the effort.
Share on Twitter Share on Facebook Share on Linkedin

The push for an independent cardiology board continues

Share on Twitter Share on Facebook Share on Linkedin
Jeff Kuvin, MD, explains the effort to create an new independent cardiology board. He is the ACC point person for the effort.
Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

FDA confirms new recall | Medtech company acquired | Trump's aspirin use | Positron raises $2M | A key approval for Edwards
Key Interviews from 2025: Questions remain about PFA's value | EARLY TAVR concerns | Medicare covers TriClip | Much more
Endovascular grafts recalled due to safety risk | FDA confirms recalls for J&J, Medtronic | ASE looks back at a busy year
Top Cardiology Video Interviews in 2025
2025 in Review: Recalls, lawsuits & the best heart hospitals in the United States
December's Top Stories: FDA panel votes against J&J device | Trump's health | CPT code updates | Cardiologist dies after arrest
New strategies for the cath lab | The first surgery of its kind | CMS considers coverage for asymptomatic TAVR | PAD & diabetes

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …32
    • Page 33
    • Page 34
    • Page 35
    • Current page 36
    • Page 37
    • Page 38
    • Page 39
    • Page 40 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup